$ECOR
electroCore, Inc. Stock $ecor

$ecor Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000121390021014871 Filed on March 11, 2021

Income Statement

Concept	2021 Q1	2020	2019 Q4
Revenue	$1.204M	$3.496M	$670.0K
YoY Change	64.08%	46.25%	82.07%
Cost Of Revenue	$364.0K	$1.738M	$390.0K
YoY Change	22.1%	50.18%	105.26%
Gross Profit	$840.0K	$1.758M	$280.0K
YoY Change	92.81%	42.57%	55.56%
Gross Profit Margin	69.77%	50.3%	41.79%
Selling, General & Admin	$5.725M	$21.84M	$7.270M
YoY Change	-12.74%	-38.34%	-41.37%
% of Gross Profit	681.55%	1242.17%	2596.43%
Research & Development	$499.0K	$4.201M	$1.620M
YoY Change	-67.24%	-57.57%	-53.18%
% of Gross Profit	59.4%	238.94%	578.57%
Depreciation & Amortization	$96.00K	$399.2K	$100.0K
YoY Change	-1.46%	59.96%	233.33%
% of Gross Profit	11.43%	22.71%	35.71%
Operating Expenses	$6.224M	$26.51M	$8.890M
YoY Change	-26.33%	-43.99%	-43.94%
Operating Profit	-$5.384M	-$24.75M	-$8.610M
YoY Change	-32.81%	-46.3%	-45.09%
Interest Expense	$0.00	$80.00K	$120.0K
YoY Change	-100.0%	-91.75%	-72.09%
% of Operating Profit
Other Income/Expense, Net		$66.57K	$0.00
YoY Change		-93.05%	-100.0%
Pretax Income	-$5.384M	-$24.68M	-$8.480M
YoY Change	-32.36%	-45.31%	-44.72%
Income Tax		-$1.171M	$20.00K
% Of Pretax Income
Net Earnings	-$5.384M	-$23.51M	-$8.500M
YoY Change	-32.36%	-47.92%	-44.57%
Net Earnings / Revenue	-447.18%	-672.55%	-1268.66%
Basic Earnings Per Share
Diluted Earnings Per Share	-$112.9K	-$602.8K	-$288.1K
COMMON SHARES
Basic Shares Outstanding	48.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q1	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.45M	$22.63M	$24.06M
YoY Change	63.16%	-5.94%	-64.91%
Cash & Equivalents	$9.064M	$4.240M	$13.56M
Short-Term Investments	$16.39M	$18.39M	$10.50M
Other Short-Term Assets	$900.0K	$1.290M	$1.100M
YoY Change	12.5%	18.35%	-42.11%
Inventory	$944.7K	$880.0K	$891.0K
Prepaid Expenses
Receivables	$259.3K	$270.0K	$496.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.59M	$25.06M	$26.53M
YoY Change	58.62%	-5.54%	-63.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$220.3K	$760.0K	$345.2K
YoY Change	-30.44%	-57.3%	-9.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$757.0K	$5.690M	$1.132M
YoY Change	-29.12%	-20.42%	166.47%
Total Long-Term Assets	$6.157M	$6.460M	$8.928M
YoY Change	-31.35%	-27.66%	1008.0%
TOTAL ASSETS
Total Short-Term Assets	$27.59M	$25.06M	$26.53M
Total Long-Term Assets	$6.157M	$6.460M	$8.928M
Total Assets	$33.75M	$31.52M	$35.46M
YoY Change	28.02%	-11.11%	-51.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.110M	$2.080M	$5.209M
YoY Change	-42.13%	-60.08%	93.0%
Accrued Expenses	$2.152M	$3.340M	$3.337M
YoY Change	-32.46%	-12.57%	-23.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$500.0K	$480.0K	$100.0K
YoY Change		336.36%
Total Short-Term Liabilities	$5.345M	$5.890M	$9.145M
YoY Change	-27.26%	-35.56%	29.29%
LONG-TERM LIABILITIES
Long-Term Debt	$900.0K	$1.100M	$0.00
YoY Change
Other Long-Term Liabilities	$900.0K	$890.0K	$1.400M
YoY Change	-30.77%	-37.32%	600.0%
Total Long-Term Liabilities	$1.800M	$1.990M	$1.400M
YoY Change	38.46%	40.14%	600.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.345M	$5.890M	$9.145M
Total Long-Term Liabilities	$1.800M	$1.990M	$1.400M
Total Liabilities	$7.083M	$8.510M	$10.56M
YoY Change	-17.93%	-24.02%	44.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$112.4M		-$83.48M
YoY Change	22.9%		117.78%
Common Stock	$48.49K		$107.8M
YoY Change	-99.96%		3.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.03M	$23.01M	$24.26M
YoY Change
Total Liabilities & Shareholders Equity	$33.75M	$31.52M	$35.46M
YoY Change	28.02%	-11.11%	-51.76%

Cashflow Statement

Concept	2021 Q1	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	-$5.384M	-$23.51M	-$8.500M
YoY Change	-32.36%	-47.92%	-44.57%
Depreciation, Depletion And Amortization	$96.00K	$399.2K	$100.0K
YoY Change	-1.46%	59.96%	233.33%
Cash From Operating Activities	-$4.156M	-$20.05M	-$9.120M
YoY Change	-51.05%	-55.51%	-25.12%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.920M	-$7.960M	$16.49M
YoY Change	-81.71%	-115.6%	-354.87%
Cash From Investing Activities	$1.917M	-$7.963M	$16.49M
YoY Change	-81.74%	-115.62%	-354.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.920M	$18.90M	-300.0K
YoY Change		11650.64%	500.0%
NET CHANGE
Cash From Operating Activities	-$4.156M	-$20.05M	-9.120M
Cash From Investing Activities	$1.917M	-$7.963M	16.49M
Cash From Financing Activities	$6.920M	$18.90M	-300.0K
Net Change In Cash	$4.822M	-$9.322M	7.070M
YoY Change	134.45%	-256.31%	-137.81%
FREE CASH FLOW
Cash From Operating Activities	-$4.156M	-$20.05M	-$9.120M
Capital Expenditures			$0.00
Free Cash Flow		-$20.05M	-$9.120M
YoY Change		-55.58%	-25.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29835183	shares
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segments
CY2020	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	Trade credits are discounts that are contingent upon a timely remittance of payment and are estimated based on historical experience. Damaged or defective products are replaced at no charge under the Company’s standard warranty. A cash refund is allowed under specific circumstances for undamaged and non-defective returned products.
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29835183	shares
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001560258
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45559765	shares
CY2020Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P7M
CY2019Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P7M
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2020	dei	Entity File Number EntityFileNumber	001-38538
CY2020	dei	Entity Registrant Name EntityRegistrantName	electroCore, Inc.
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3454976
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4241937	USD
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Forge Way
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockaway
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07866
CY2020	dei	City Area Code CityAreaCode	(973)
CY2020	dei	Local Phone Number LocalPhoneNumber	290-0097
CY2020	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.001 Per Share
CY2020	dei	Trading Symbol TradingSymbol	ECOR
CY2020Q2	dei	Entity Public Float EntityPublicFloat	27865926	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48476785	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13563791	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18386160	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10495350	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	270546	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	496140	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	876436	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	890992	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1288588	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1087111	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	25063667	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	26533384	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	6020180	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	244047	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	345236	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517257	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1430641	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	828011	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1132238	USD
CY2020Q4	us-gaap	Assets Assets	31518163	USD
CY2019Q4	us-gaap	Assets Assets	35461679	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2078699	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5208979	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2800820	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3337379	USD
CY2020Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	476236	USD
CY2019Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	111878	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	534547	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9144681	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1097946	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	885333	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1419880	USD
CY2020Q4	us-gaap	Liabilities Liabilities	7873581	USD
CY2019Q4	us-gaap	Liabilities Liabilities	10564561	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45559765	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29835183	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	45560	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	29835	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	130205027	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	107752066	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106990148	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-83479098	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-251467	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41295	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23008972	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	24261508	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	635610	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	635610	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23644582	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24897118	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31518163	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35461679	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3495832	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2390279	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1737539	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1156957	USD
CY2020	us-gaap	Gross Profit GrossProfit	1758293	USD
CY2019	us-gaap	Gross Profit GrossProfit	1233322	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4201279	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9902254	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21840919	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35422301	USD
CY2020	ecor	Restructuring And Other Severance Related Charges RestructuringAndOtherSeveranceRelatedCharges	464606	USD
CY2019	ecor	Restructuring And Other Severance Related Charges RestructuringAndOtherSeveranceRelatedCharges	1997292	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	26506804	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	47321847	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-24748511	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-46088525	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	84327	USD
CY2019	us-gaap	Interest And Other Income InterestAndOtherIncome	970594	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	17756	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	12253	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	66571	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	958341	USD
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29379975	shares
CY2020	us-gaap	Profit Loss ProfitLoss	-23511050	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-45147883	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-23721222	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-45250021	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24681940	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45130184	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1170890	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17699	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23511050	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-45147883	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.54
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38998698	shares
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-207012	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-145418	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3160	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	43280	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-210172	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-102138	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66185701	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-45147883	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-102138	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	16692	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48965	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3895781	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24897118	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23511050	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-210172	USD
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	19385196	USD
CY2020	ecor	Equity Financing Commitment Fees EquityFinancingCommitmentFees		USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	182821	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue		USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23644582	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-23511050	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-45147883	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	3266311	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3895781	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399242	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	249583	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-31096	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	530104	USD
CY2020	ecor	Adjustments Of Cloud Computing Implementation Cost AdjustmentsOfCloudComputingImplementationCost		USD
CY2019	ecor	Adjustments Of Cloud Computing Implementation Cost AdjustmentsOfCloudComputingImplementationCost	-1114568	USD
CY2020	ecor	Legal Expense Settled With Stock LegalExpenseSettledWithStock	156434	USD
CY2019	ecor	Legal Expense Settled With Stock LegalExpenseSettledWithStock		USD
CY2020	ecor	Noncash Lease Expense Net NoncashLeaseExpenseNet	372304	USD
CY2019	ecor	Noncash Lease Expense Net NoncashLeaseExpenseNet	57780	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	433918	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown		USD
CY2020	ecor	Write Off Of Right Of Use Operating Lease WriteOffOfRightOfUseOperatingLease	-557543	USD
CY2019	ecor	Write Off Of Right Of Use Operating Lease WriteOffOfRightOfUseOperatingLease		USD
CY2020	ecor	Litigation Settlement Non Cash LitigationSettlementNonCash		USD
CY2019	ecor	Litigation Settlement Non Cash LitigationSettlementNonCash	-16692	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-676	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-76279	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-225594	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	228541	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-735637	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4961770	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	165707	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-859204	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1581579	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2797727	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-536561	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1036721	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-486445	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20102587	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45066541	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24463158	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	37224879	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16500000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	88266000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69675	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7963158	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	50971446	USD
CY2020	ecor	Proceeds From Shares Issued Net Of Related Expenses ProceedsFromSharesIssuedNetOfRelatedExpenses	17489563	USD
CY2019	ecor	Proceeds From Shares Issued Net Of Related Expenses ProceedsFromSharesIssuedNetOfRelatedExpenses		USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2558360	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	807347	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1096056	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	695469	USD
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans		USD
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	48965	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18951867	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	160843	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-207976	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-102241	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9321854	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5963507	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13563791	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7600284	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4241937	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13563791	USD
CY2020	ecor	Proceeds From Sale Of State Net Operating Losses ProceedsFromSaleOfStateNetOperatingLosses	1170890	USD
CY2019	ecor	Proceeds From Sale Of State Net Operating Losses ProceedsFromSaleOfStateNetOperatingLosses		USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3769	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29542	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	12895	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3457	USD
CY2020	ecor	Accounts Payable Paid Through Issuance Of Common Stock AccountsPayablePaidThroughIssuanceOfCommonStock	1548702	USD
CY2019	ecor	Accounts Payable Paid Through Issuance Of Common Stock AccountsPayablePaidThroughIssuanceOfCommonStock		USD
CY2020	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.958	pure
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="background-color: #ffffff; margin: 0px; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(c) Use of Estimates</span></p> <p style="background-color: #ffffff; margin: 6pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with U.S.</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> GAAP</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include <span style="color: #000000; font-family: &quot; times new roman&quot;; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">valuation of inventory</span><span style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">, stock compensation, and contingencies.</span></span></p>
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0px; text-indent: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-style: italic; font-weight: bold;">(g) Concentration of Credit Risk </span></p> <p style="margin: 6pt 0pt 0pt;"><br/></p> <p style="margin-top: 6.0pt;"><span style="font-family: 'times new roman', times;"><span style="font-size: 10.0pt;">Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. As of December 31, 2020, the Company's cash equivalents and marketable securities were largely comprised of money market funds and U.S. treasury bonds. The Company has established <span style="mso-comment-continuation: 2;"><span style="mso-comment-continuation: 3;">guidelines </span></span></span><span style="font-size: 10.0pt;">relative to diversification and maturities that are designed to help ensure safety and liquidity. These guidelines are periodically reviewed to take advantage of trends in yields and interest rates. As of December 31, 2020, approximately 95.8% of the Company’s cash, cash equivalents and marketable securities was denominated in U.S. Dollars, the balance is subject to foreign exchange risk.</span></span></p> <p style="margin-top: 6.0pt;"><span style="font-family: 'times new roman', times;"><span style="font-size: 10.0pt;"><br/></span></span></p>
CY2020	ecor	Leasehold Improvements Term LeaseholdImprovementsTerm	Lesser of estimated useful life or term of lease
CY2020Q1	ecor	Maximum Amount Of Reduction In Monthly Co Payments Of Each Prescription MaximumAmountOfReductionInMonthlyCoPaymentsOfEachPrescription	100	USD
CY2019	ecor	Payment Term For Customers PaymentTermForCustomers	P120D
CY2020Q4	ecor	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	4241937	USD
CY2020Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax		USD
CY2020	ecor	Recent Accounting Pronouncements Not Yet Adopted RecentAccountingPronouncementsNotYetAdopted	<p style="margin: 0px; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(t) Recently Accounting Standards Not Yet Adopted </span></p> <p style="margin: 6pt 0pt 0pt;"><span style="float: none; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; display: inline !important;">In December 2019, the FASB issued an update to simplify the accounting for income taxes and improve consistent application by clarifying or amending existing guidance. This guidance is effective for the year ended December 31, 2021. The Company does not expect this guidance to have a material impact on its consolidated financial statements upon adoption.<br/></span></p>
CY2020	ecor	Net Losses NetLosses	23.5	USD
CY2019	ecor	Net Losses NetLosses	45100000	USD
CY2020Q4	ecor	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	107.0	USD
CY2020Q4	ecor	Number Of Channels NumberOfChannels	2	Channels
CY2020Q4	ecor	Number Of Channels NumberOfChannels	2	Channels
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3495832	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2390279	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	USD
CY2020Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax		USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4241937	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18388970	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2810	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18386160	USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent	22630907	USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent		USD
CY2020Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent	2810	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	22628097	USD
CY2019Q4	ecor	Cash And Cash Equivalents Amortized Cost CashAndCashEquivalentsAmortizedCost	13564252	USD
CY2019Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax		USD
CY2019Q4	ecor	Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax	461	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13563791	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10494539	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	811	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10495350	USD
CY2019Q4	ecor	Cash And Cash Equivalents And Marketable Securities Amortized Cost Basis Current CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCostBasisCurrent	24058791	USD
CY2019Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gains Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainsBeforeTaxCurrent	811	USD
CY2019Q4	ecor	Cash And Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax Current CashAndCashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent	461	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	24059141	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4241937	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	22628097	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	13563791	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	24059141	USD
CY2020Q4	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	1008653	USD
CY2019Q4	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	1065345	USD
CY2020Q4	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	4304415	USD
CY2019Q4	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	5314763	USD
CY2020Q4	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	428549	USD
CY2019Q4	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	531064	USD
CY2020Q4	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	5741617	USD
CY2019Q4	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	6911172	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	4865181	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	6020180	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	876436	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	890992	USD
CY2020Q4	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	700000	USD
CY2019Q4	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	1000000.0	USD
CY2019Q4	ecor	Inventory Noncurrent Work In Process InventoryNoncurrentWorkInProcess	5000000.0	USD
CY2020	ecor	Lease Effective Date LeaseEffectiveDate	2019-01-01
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4200000	USD
CY2020	ecor	Lease Not Yet Recognized With Noncancelable Period Description LeaseNotYetRecognizedWithNoncancelablePeriodDescription	12 months or less
CY2020	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	up to an additional five years
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0975	pure
CY2020	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.1375	pure
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	573046	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	787952	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517257	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1430641	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	534547	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	486445	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	885333	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1419880	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1906325	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1375	pure
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1375	pure
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	786584	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	337254	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	142892	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	146044	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	149700	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	526560	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2089034	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	669154	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1419880	USD
CY2020	ecor	Amortization Of Deferred Costs AmortizationOfDeferredCosts	282075	USD
CY2019	ecor	Amortization Of Deferred Costs AmortizationOfDeferredCosts	141037	USD
CY2020Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y
CY2020	ecor	Cloud Computing Arrangement CloudComputingArrangement	1222322	USD
CY2019	ecor	Cloud Computing Arrangement CloudComputingArrangement	1222322	USD
CY2020	ecor	Less Accumulated Amortization LessAccumulatedAmortization	423112	USD
CY2019	ecor	Less Accumulated Amortization LessAccumulatedAmortization	141037	USD
CY2020	ecor	Cloud Computing Arrangement Net CloudComputingArrangementNet	799210	USD
CY2019	ecor	Cloud Computing Arrangement Net CloudComputingArrangementNet	1081285	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	270543	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1255494	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1424878	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	804082	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	371033	USD
CY2019Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	836754	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	734366	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	441049	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2800820	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3337379	USD
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-02-02
CY2020Q4	us-gaap	Debt Current DebtCurrent	311604	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1097946	USD
CY2020Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1200000	USD
CY2020Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0218	pure
CY2020Q3	us-gaap	Notes Payable NotesPayable	164800	USD
CY2019Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	807347	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	341	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	3457	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2058822	shares
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1170890	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7712	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1170890	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9987	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1170890	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17699	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5215463	shares
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	715199	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5570552	shares
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-23706566	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-43661897	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-975373	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1468287	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45130184	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	355288	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	202580	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	78206	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17699	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24319202	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18883686	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	540072	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	796849	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	429783	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	27019	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent		USD
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	11277	USD
CY2019Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	19028	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	438117	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	394981	USD
CY2020Q4	ecor	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	398689	USD
CY2019Q4	ecor	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	518480	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3069124	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	750449	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29435863	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21796967	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28974378	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21171967	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	461485	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	625000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	16119	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	15222	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	300125	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	220673	USD
CY2020Q4	ecor	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	145241	USD
CY2019Q4	ecor	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	389105	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	461485	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	625000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.067	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.068	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent		pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1339372	shares
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2020	ecor	Period For Cumulative Change In Ownership PeriodForCumulativeChangeInOwnership	P3Y
CY2020Q4	ecor	Cumulative Change In Ownership Percentage CumulativeChangeInOwnershipPercentage	0.50	pure
CY2020	ecor	Federal Research And Development FederalResearchAndDevelopment	282801	USD
CY2020Q4	ecor	Nj Research And Development NJResearchAndDevelopment	191863	USD
CY2020Q1	ecor	Taxable Income Offset Percentage TaxableIncomeOffsetPercentage	1	pure
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5000000.0	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.037	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.005	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001	pure
CY2020	ecor	Effective Income Tax Rate Reconciliation Loss Incurred As Pass Through Percentage EffectiveIncomeTaxRateReconciliationLossIncurredAsPassThroughPercentage		pure
CY2019	ecor	Effective Income Tax Rate Reconciliation Loss Incurred As Pass Through Percentage EffectiveIncomeTaxRateReconciliationLossIncurredAsPassThroughPercentage		pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	0.001	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther		pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.276	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.047	pure
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3266311	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3895781	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3131266	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.53
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2019298	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.33
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1334979	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.93
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3815585	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.56
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.21
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	47883	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2019Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5192	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.68
CY2020	ecor	Payment In Lieu Of Severance PaymentInLieuOfSeverance	175000	USD
CY2019	ecor	Payment In Lieu Of Severance PaymentInLieuOfSeverance		USD
CY2020	us-gaap	Other Restructuring Costs OtherRestructuringCosts	18442	USD
CY2019	us-gaap	Other Restructuring Costs OtherRestructuringCosts		USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.98
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.39
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.342	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.959	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021	pure
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2020	ecor	Maximum Company Matching Contribution MaximumCompanyMatchingContribution	0.25
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	15600	USD
CY2020Q4	us-gaap	Purchase Obligation PurchaseObligation	2300000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	271164	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	1997292	USD
CY2020	ecor	Restructuring And Other Related Charges RestructuringAndOtherRelatedCharges	464606	USD
CY2019	ecor	Restructuring And Other Related Charges RestructuringAndOtherRelatedCharges	1997292	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	25000	USD
CY2019Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	32	Employee

Files In Submission

Name	View Source	Status
0001213900-21-014871-index-headers.html	Edgar Link	pending
0001213900-21-014871-index.html	Edgar Link	pending
0001213900-21-014871.txt	Edgar Link	pending
0001213900-21-014871-xbrl.zip	Edgar Link	pending
ecor-20201231.htm	Edgar Link	pending
ecor-20201231.xsd	Edgar Link	pending
ecor-20201231_cal.xml	Edgar Link	unprocessable
ecor-20201231_def.xml	Edgar Link	unprocessable
ecor-20201231_htm.xml	Edgar Link	completed
ecor-20201231_lab.xml	Edgar Link	unprocessable
ecor-20201231_pre.xml	Edgar Link	unprocessable
ex1014_2.htm	Edgar Link	pending
ex211_3.htm	Edgar Link	pending
ex231_4.htm	Edgar Link	pending
ex232_5.htm	Edgar Link	pending
ex311_6.htm	Edgar Link	pending
ex312_7.htm	Edgar Link	pending
ex321_8.htm	Edgar Link	pending
ex322_9.htm	Edgar Link	pending
ex42_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ECOR
electroCore, Inc. Stock $ecor

2021 Q1 Form 10-K Financial Statement

#000121390021014871 Filed on March 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR electroCore, Inc. Stock $ecor

2021 Q1 Form 10-K Financial Statement

#000121390021014871 Filed on March 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR
electroCore, Inc. Stock $ecor